Fennec Pharmaceuticals(DE:RV41)
€11.40+0.90 (+8.57%)
DE:RV41
Fennec Pharmaceuticals earnings date
€11.40
At close:+0.90 (+8.57%)
Fennec Pharmaceuticals (RV41) Q2 2021 Earnings Report
0 Followers
DE:RV41 Q2 2021 EPS Results
- Actual EPS
- -EUR 0.12
- Consensus EPS
- -EUR 0.21
- Beat/Miss
- Beat by +EUR 0.09
- One Year Ago EPS
- -EUR 0.18
DE:RV41 Q2 2021 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/10/2021
- Time
- Before Open
- Conference Call
- Tuesday, August 10, 2021
DE:RV41 Upcoming Earnings
Fennec Pharmaceuticals's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RV41 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | 0.14- | -0.15 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | 0.090.11 | -0.02 | 700.00% (+0.13) | |
| Aug 11, 2026 | 2026 (Q2) | 0.020.05 | -0.1 | 145.45% (+0.15) | |
| May 14, 2026 | 2026 (Q1) | -0.040.01 | -0.04 | 125.00% (+0.05) | |
| Mar 24, 2026 | 2025 (Q4) | 0.04-0.15 | -0.05 | -183.33% (-0.10) | |
| Nov 13, 2025 | 2025 (Q3) | -0.02-0.02 | -0.19 | 90.48% (+0.17) | |
| Aug 14, 2025 | 2025 (Q2) | -0.03-0.10 | -0.18 | 45.00% (+0.08) | |
| May 13, 2025 | 2025 (Q1) | -0.08-0.04 | 0.37 | -109.76% (-0.41) | |
| Mar 10, 2025 | 2024 (Q4) | -0.12-0.05 | -0.09 | 40.00% (+0.04) | |
| Nov 07, 2024 | 2024 (Q3) | -0.08-0.19 | -0.06 | -200.00% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

